According to the preliminary accounting of the financial department of tonghua dongbao Pharmaceutical Co., Ltd., it is estimated that the net profit attributable to the owners of the parent company in 20 13 will increase by 190%-220% compared with the same period of last year. The main reason for the increase in performance is 1. During the reporting period, the company stepped up market expansion, and the operating income of recombinant human insulin products increased compared with the same period of last year, resulting in an increase in net profit compared with the same period of last year. 2. During the reporting period, the company strengthened internal management, and the provision for bad debts decreased compared with the same period of last year, resulting in an increase in net profit compared with the same period of last year. It seems strange that the performance has increased in advance but the stock price has fallen. In fact, it is easy to understand, indicating that the pre-increased performance did not meet the expectations of fund positions. The fund's gameplay is often that regardless of the price and price, the performance meets expectations and the growth meets expectations. Holding shares, but lower than expected, broke out; What's more, the stock has been continuously rising in the early stage, and the cash of good news will also lead to the shipment of funds with good help; I hope my answer can help you, and I wish you a happy Spring Festival.